ESR1 and breast cancer: Triple-negative breast cancer (TNBC) is a biologically aggressive subtype of breast cancer, characterized by the absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) expression [2].